INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30100% above fair value

$121.16+3.09 (+2.62%)

Close on Nov 13, 2026Market cap $26.58BP/E –Yield –

Insmed statistics

86 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 18, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $26.58B; $272.32M
Enterprise Value: $25.99B; $146.23M
PS Ratio: 17.49; 3.66
PB Ratio: 36.60; 2.00
P/TBV Ratio: 58.85; 2.22

Enterprise valuationIndustry

EV / Sales: 17.10; 2.57

Share statisticsIndustry

Shares Outstanding: 219M; 58M
Shares Change (YoY): 13.7%; 10.8%
Shares Change (QoQ): 0.48%; 0.50%
Float: 217M; 49M
Shares Held by Insiders: 0.89%; 11.7%
Shares Held by Institutions: 102.0%; 56.4%

Short sellingIndustry

Short Interest: 14M; –
Short Interest Change: 4.47%; -0.80%
Short % of Float: 6.48%; 9.01%
Short % of Shares Outstanding: 6.42%; 6.30%
Days to Cover: 3.56; 5.15

Stock price statisticsIndustry

52-Week High: $212.75; –
52-Week Low: $90.39; –
20-Day Moving Average: $106.27; –
50-Day Moving Average: $110.82; –
200-Day Moving Average: $123.16; –
Average True Range (14): $4.89; –
Price Change (1 Week): 5.90%; -1.15%
Price Change (1 Month): 22.1%; -4.87%
Price Change (3 Months): -5.58%; -21.0%
Price Change (6 Months): 11.0%; -20.6%
Price Change (YTD): -30.4%; -23.6%
Price Change (1 Year): -37.7%; -22.4%
Price Change (3 Years): 393.7%; -29.5%
Price Change (5 Years): 280.3%; -77.9%
Price Change (10 Years): 701.9%; -65.4%
Average Volume (10 Days): 3M; –
Average Volume (20 Days): 4M; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.54; 0.70
Relative Strength Index (14): 65.0; 43.4
Volatility (1 Year): 63.0%; 80.1%
Beta (5 Years): 0.75; 1.07

MarginsIndustry

Gross Margin: 84.4%; 53.1%
Operating Margin: -37.1%; -38.7%
Pretax Margin: -39.4%; -11.6%
Profit Margin: -39.9%; -31.6%
EBITDA Margin: -37.1%; -27.7%
FCF Margin: -41.3%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): -72.5%; -49.9%
Return on Assets (ROA): -26.4%; -40.6%
Return on Capital Employed (ROCE): -34.6%; -37.9%

Financial positionIndustry

Current Ratio: 2.86; 3.30
Quick Ratio: 2.36; 2.39
Debt / Equity: 0.76; 0.49
Interest Coverage: -6.93; -6.35

GrowthIndustry

Revenue Growth (YoY): 240.0%; 6.82%
Revenue Growth (3Y CAGR): 35.2%; 2.25%
Revenue Growth (5Y CAGR): 29.8%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.66; 0.40
Inventory Turnover: 1.66; 2.73
Revenue Per Employee: $913.29K; $429.29K
Profits Per Employee: -$363.95K; -$689.41K
Employee Count: 1,664; 74
WACC: 8.93%; 10.2%

Income statement (TTM)Industry

Revenue: $1.52B; $66.37M
Gross Profit: $1.28B; $120.78M
Operating Income: -$563.99M; -$21.37M
Pretax Income: -$598.06M; -$12.95M
Net Income: -$605.61M; -$22.35M
EBITDA: -$563.99M; -$17.21M
EPS (Diluted): -$2.82; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $1.15B; $68.68M
Total Debt: $555.09M; $116.91M
Net Cash (Debt): $591.53M; $17.76M
Net Cash Per Share: $2.70; $0.80
Equity (Book Value): $726.21M; $53.89M
Book Value Per Share: $3.31; $1.50
Tangible Book Value: $451.67M; $27.13M
Working Capital: $1.11B; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$595.62M; -$12.38M
Capital Expenditures: -$31.95M; -$1.00M
Free Cash Flow: -$627.58M; -$18.21M
FCF Per Share: -$2.86; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -2.28%; -21.8%
FCF Yield: -2.36%; -9.44%

Taxes and interestIndustry

Interest Expense: $81.36M; $2.90M
Income Tax: $7.55M; $73.00K

Scores and fair valueIndustry

Altman Z-Score: 7.36; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	INSM	S&P 500	Difference	INSM per year	S&P 500 per year
1 month	+25.2%	-3.0%	+28.2 pts
3 months	-4.1%	-2.8%	−1.3 pts
Year to date	-30.4%	+11.5%	−41.9 pts
1 year	-36.6%	+13.5%	−50.0 pts
3 years	+406.9%	+77.7%	+329.2 pts	+71.8%	+21.1%
5 years	+280.3%	+72.6%	+207.7 pts	+30.6%	+11.5%
10 years	+738.5%	+308.2%	+430.3 pts	+23.7%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

14M INSM shares were sold short on Oct 30, 2026, up 4.5% from the previous report, or 6.48% of the shares available to trade. At recent volumes it would take 3.6 days to buy them back. Over the last 20 sessions, 41.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	14,080,405	+4.5%	3,955,688	3.6
Oct 15, 2026	13,477,593	-2.3%	3,261,711	4.1
Sep 30, 2026	13,800,693	+27.8%	2,123,248	6.5
Sep 15, 2026	10,802,070	-5.6%	2,049,480	5.3
Aug 31, 2026	11,440,176	+5.0%	1,668,674	6.9
Aug 14, 2026	10,892,278	-4.0%	4,091,987	2.7
Jul 31, 2026	11,350,580	-2.4%	2,207,650	5.1
Jul 15, 2026	11,624,756	-27.5%	2,440,598	4.8
Jun 30, 2026	16,030,053	-14.0%	5,800,443	2.8
Jun 15, 2026	18,647,626	-2.5%	4,164,071	4.5
May 29, 2026	19,132,984	+8.7%	3,132,399	6.1
May 15, 2026	17,606,497	+19.7%	5,214,392	3.4